Literature DB >> 11865635

[Development of a Japanese version of the FLIE].

Atsushi Satou1, Tamaki Yamazaki, Naotaka Nukariya, Masatoshi Nakamachi, Ken Shimada, Masaaki Matsukawa, Minoru Kurihara.   

Abstract

Nausea and vomiting induced by chemotherapy have an impact on cancer patients' quality of life (QOL). The Functional Living Index-Emesis (FLIE), which is designed to assess the change in QOL from the influence of nausea and vomiting is rarely used in Japan, regardless of its utility, because it is written in English. We investigated the use by cancer patients with the main object of designing a reliable and valid Japanese version of the FLIE. We also verified the validity of a Japanese translation and improved part to design a highly precise Japanese version FLIE. Consequently, we found a correlation between the FLIE Japanese version and the QOL questionnaire Quality of Life Assessment of Cancer Patients Receiving Chemotherapy (QOL-ACPRC), which was the external standard. Furthermore, we improved the questionnaire to raise the rate of patient response, and improve reliability and validity. We think that this FLIE Japanese version will become useful in assessing the change in patient QOL due to the influence of nausea and vomiting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11865635

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  3 in total

Review 1.  A review of patient self-report tools for chemotherapy-induced nausea and vomiting.

Authors:  Sarah G Brearley; Caroline V Clements; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2008-06-13       Impact factor: 3.603

2.  Aprepitant plus granisetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.

Authors:  Katsunobu Oyama; Sachio Fushida; Masahide Kaji; Toshiya Takeda; Shinichi Kinami; Yasuo Hirono; Katsuhiro Yoshimoto; Kazuhisa Yabushita; Hisashi Hirosawa; Yuki Takai; Tatsuo Nakano; Hironobu Kimura; Toshiaki Yasui; Atsushi Tsuneda; Tomoya Tsukada; Jun Kinoshita; Takashi Fujimura; Tetsuo Ohta
Journal:  J Gastroenterol       Date:  2013-01-22       Impact factor: 7.527

3.  Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.

Authors:  Katsunobu Oyama; Sachio Fushida; Masahide Kaji; Toshiya Takeda; Kazuhisa Yabushita; Hideaki Nezuka; Shinichi Kinami; Naotaka Kadoya; Yuki Takai; Yuji Tsukioka; Shigekazu Ohyama; Kunihiro Tsuji; Tomoya Tsukada; Jun Kinoshita; Takashi Fujimura; Tetsuo Ohta
Journal:  Int J Clin Oncol       Date:  2015-10-27       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.